Kaposi’s Sarcoma: Cancer of the Blood and Lymph

Stages of Kaposi’s Sarcoma

When a diagnosis of Kaposi’s sarcoma is made, medical professionals often undertake an assessment to determine the extent and spread of the condition. The AIDS Clinical Trial Group system is commonly used by doctors to stage Kaposi’s sarcoma. This system takes into account three key factors: the size and spread of the tumor, the condition of the immune system, and the level of systemic illness present.

Within each of these three groups, there are two categories that indicate whether the prognosis is favorable (0) or poor (1). For instance, a T0 ranking signifies that the tumor is confined to a small area, while a T1 ranking indicates that the lesions have spread extensively and pose a significant risk.


Treatment

Kaposi’s sarcoma is a condition for which there is currently no cure. However, the treatment options available focus on addressing various factors associated with the disease. In the case of epidemic Kaposi’s sarcoma, medications that enhance immune system activity have proven to be effective. Individuals who have undergone a transplant may choose to discontinue their immunosuppressant drugs or explore alternative options. Minor surgical procedures can be employed to treat skin lesions that may develop. Patients with multiple skin lesions often undergo radiation therapy. In situations where Kaposi’s sarcoma has spread to internal organs, chemotherapy is considered the most viable and efficient treatment choice.

5 of 5NEXT